Skip to main content
Displaying 13 - 24 of 90
Display:
12
24
48
Cirrhosis & Complications
6
Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
5
GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
5
GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
5
GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
5
GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
5
GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022
View
General Hepatology
5
Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022
View
General Hepatology
5
Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022
View
General Hepatology
5
Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022
View
General Hepatology
5
Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022
View
General Hepatology
5
Orphalan: Chelating Evidence: Achieving More for Patients with Wilson’s Disease - ILC 2022
View
Viral Hepatitis
5
Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy